Company / Cash per Share
Cardiff Oncology, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.26
FY2025
5-year range
$0.26 / $1.15
FY2021-FY2025
Trend
-77.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 10 years, ranging from $0.26 in FY2025 to $15.24 in FY2020.
Based on SEC 10-K filings.
0.26 in FY2025 with a 5-year CAGR of -55.6%.
Declined from $0.48 to $0.26 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -12.3%
- 5-Year CAGR
- -55.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 77.2% year-over-year.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | -77.2% |
| FY2024 | $1.15 | +137.7% |
| FY2023 | $0.48 | +24.4% |
| FY2022 | $0.39 | +20.0% |
| FY2021 | $0.32 | -97.9% |
| FY2020 | $15.24 | +472.9% |
| FY2019 | $2.66 | -76.3% |
| FY2018 | $11.22 | +2374.9% |
| FY2017 | $0.45 | -50.6% |
| FY2016 | $0.92 | -74.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026